Publication | Closed Access

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial

ThrombosisPercutaneous Coronary InterventionDual Antiplatelet TherapyCardiovascular DiseasePrasugrel-based De-escalationClinical TrialsAcute Coronary SyndromePharmacotherapyPlatelet AntagonistMedicineCardiologyCoronary Artery DiseaseAcute Myocardial Infarction